Cognitive function and anticoagulation discontinuation in patients without long-term recurrence after catheter ablation for atrial fibrillation: A substudy of the ALONE-AF trial.

Heart RhythmApr 24, 2026 (epub)
Clinical ResearchCardiology

Ho-Gi Chung, Il-Young Oh, Jun Kim et al.

✦ AI-curated · Sources linked

In 30 seconds

This substudy of the ALONE-AF trial evaluated the cognitive effects of oral anticoagulant (OAC) discontinuation in patients aged 19-80 years without atrial fibrillation recurrence after catheter ablation. The randomized controlled trial found no significant difference in cognitive decline between those who discontinued OAC and those who continued, with a between-group difference in MoCA score change of 0.1.

Key findings

  • Mean total MoCA score increased from 24.4 to 25.0 in the no-OAC group.
  • Mean total MoCA score increased from 24.2 to 24.9 in the OAC group.
  • No significant difference in cognitive score change between no-OAC and OAC groups (P = .759).

Why it matters

Understanding the cognitive implications of OAC therapy discontinuation in patients post-ablation is crucial for managing long-term care and stroke risk. This study suggests that discontinuation may not adversely affect cognitive function in this population.

Source

Published in Heart Rhythm. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.